Total submissions: 27
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000112369 | SCV000244364 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2015-08-10 | reviewed by expert panel | curation | IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000173 |
Labcorp Genetics |
RCV000048612 | SCV000076625 | benign | Hereditary breast ovarian cancer syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000123923 | SCV000167307 | benign | not specified | 2013-12-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000162986 | SCV000213474 | benign | Hereditary cancer-predisposing syndrome | 2014-09-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000112369 | SCV000220947 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2014-12-11 | criteria provided, single submitter | literature only | |
ARUP Laboratories, |
RCV001811341 | SCV000602726 | benign | not provided | 2020-02-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162986 | SCV000683196 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000112369 | SCV000743391 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000112369 | SCV000744611 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000123923 | SCV000806956 | benign | not specified | 2017-03-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000112369 | SCV001280757 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Institute of Human Genetics, |
RCV000112369 | SCV001429384 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2019-05-07 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV000048612 | SCV002025930 | benign | Hereditary breast ovarian cancer syndrome | 2021-11-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000123923 | SCV002065803 | likely benign | not specified | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000162986 | SCV002537762 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-19 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000123923 | SCV002550971 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000735456 | SCV003838237 | likely benign | Breast and/or ovarian cancer | 2022-05-30 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000112369 | SCV004016781 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001811341 | SCV004140623 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | BRCA1: BP4, BS1, BS2 |
Institute for Biomarker Research, |
RCV000048612 | SCV004228047 | benign | Hereditary breast ovarian cancer syndrome | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001811341 | SCV005251035 | benign | not provided | criteria provided, single submitter | not provided | ||
Breast Cancer Information Core |
RCV000112369 | SCV000145135 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2002-05-29 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001353447 | SCV000591529 | benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The p.Asp1646Asn variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located near a splice junction, is listed in dbSNP (rs28897691) and EVS as a low frequency variant, and is reported as benign in XXX# publications (${MatchVariant_1_ReferenceSummary}). | |
Foulkes Cancer Genetics LDI, |
RCV000735456 | SCV000863593 | benign | Breast and/or ovarian cancer | 2013-03-28 | no assertion criteria provided | clinical testing | |
Clinical Genetics Laboratory, |
RCV000123923 | SCV001906156 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000123923 | SCV001959251 | benign | not specified | no assertion criteria provided | clinical testing | ||
BRCAlab, |
RCV000112369 | SCV004243978 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2020-03-02 | no assertion criteria provided | clinical testing |